Exousia Pro, Inc. (MAJI)
OTCMKTS · Delayed Price · Currency is USD
0.0440
-0.0020 (-4.35%)
Mar 26, 2026, 11:47 AM EST
Exousia Pro Market Cap
Exousia Pro has a market cap or net worth of $1.94 million as of March 26, 2026. Its market cap has increased by 103.97% in one year.
Market Cap
1.94M
Enterprise Value
2.64M
Revenue
-12.83K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since May 2, 2011, Exousia Pro's market cap has decreased from 21.45M to 1.94M, a decrease of -90.96%. That is a compound annual growth rate of -14.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 1.94M | -14.00% |
| Dec 31, 2025 | 2.25M | 16.97% |
| Dec 31, 2024 | 1.93M | -50.14% |
| Dec 28, 2023 | 3.86M | 225.30% |
| Dec 30, 2022 | 1.19M | -58.10% |
| Dec 31, 2021 | 2.83M | -84.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaccinex | 2.38M |
| VitaSpring Biomedical | 2.30M |
| ProtoKinetix | 2.13M |
| LakeShore Biopharma | 1.85M |
| ZyVersa Therapeutics | 1.80M |
| Sorrento Therapeutics | 1.69M |
| Agentix | 1.68M |
| Neon Bloom | 1.55M |